World's Best Scientists 2026 revealed!
Nicholas J. Ashton

Nicholas J. Ashton

D-Index & Metrics

Medicine

D-Index
88
Citations
28486
World Ranking
13160
National Ranking
246

Overview

Nicholas J. Ashton is affiliated with the University of Gothenburg in Sweden. Their research primarily focuses on the field of Medicine, with substantial contributions in several subfields including Physiology, Psychiatry and Mental Health, Neurology, Molecular Biology, and Cognitive Neuroscience.

Their main research topics encompass a variety of aspects related to neurological diseases and brain function. Key topical areas include:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurological Disease Mechanisms and Treatments
  • Functional Brain Connectivity Studies
  • S100 Proteins and Annexins
  • Advanced Neuroimaging Techniques and Applications

Nicholas J. Ashton has published extensively in multiple peer-reviewed journals. Their frequent publication venues include:

  • Alzheimer s & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Alzheimer s Research & Therapy
  • Brain
  • Neurology

Some of their recent papers highlight advances in biomarkers for Alzheimer's disease and neurodegeneration. Selected recent publications are:

  • Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology, 2021, Acta Neuropathologica
  • Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology, 2024, JAMA Neurology
  • A multicentre validation study of the diagnostic value of plasma neurofilament light, 2021, Nature Communications

Other notable papers co-authored by Ashton include:

  • Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts, 2020, The Lancet Neurology
  • Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum, 2021, JAMA Neurology

Frequent collaborators in their research are:

  • Kaj Blennow
  • Henrik Zetterberg
  • Thomas K. Karikari
  • Pedro Rosa-Neto
  • Andréa Lessa Benedet

Best Publications

  • Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.

    Thomas K. Karikari;Tharick A. Pascoal;Tharick A. Pascoal;Nicholas J. Ashton;Shorena Janelidze

  • The Selaginella genome identifies genetic changes associated with the evolution of vascular plants.

    Jo Ann Banks;Tomoaki Nishiyama;Mitsuyasu Hasebe;Mitsuyasu Hasebe;John L. Bowman;John L. Bowman

  • Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology

    Nicholas J. Ashton;Tharick A. Pascoal;Thomas K. Karikari;Andréa L. Benedet;Andréa L. Benedet

  • Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.

    Andréa L Benedet;Andréa L Benedet;Marta Milà-Alomà;Agathe Vrillon;Agathe Vrillon;Nicholas J Ashton

  • Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.

    Joana B Pereira;Joana B Pereira;Shorena Janelidze;Ruben Smith;Niklas Mattsson-Carlgren

  • A multicentre validation study of the diagnostic value of plasma neurofilament light.

    Nicholas J. Ashton;Shorena Janelidze;Ahmad Al Khleifat;Antoine Leuzy

  • Microglial activation and tau propagate jointly across Braak stages

    Tharick A. Pascoal;Andrea L. Benedet;Nicholas J. Ashton;Nicholas J. Ashton;Nicholas J. Ashton;Min Su Kang;Min Su Kang

  • Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.

    Nelly Kanberg;Nelly Kanberg;Nicholas J. Ashton;Nicholas J. Ashton;Lars-Magnus Andersson;Lars-Magnus Andersson;Aylin Yilmaz;Aylin Yilmaz

  • Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.

    Marc Suárez-Calvet;Thomas K Karikari;Nicholas J Ashton;Juan Lantero Rodríguez

  • Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.

    Thomas K Karikari;Andréa L Benedet;Nicholas J Ashton;Juan Lantero Rodriguez

  • The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.

    Joel Simrén;Antoine Leuzy;Thomas K Karikari;Abdul Hye

  • Steroid-Responsive Encephalitis in Coronavirus Disease 2019.

    Andrea Pilotto;Silvia Odolini;S Stefano Masciocchi;Agnese Comelli

  • Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

    Alexis Moscoso;Michel J Grothe;Michel J Grothe;Nicholas J Ashton;Thomas K Karikari

  • Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.

    Juan Lantero Rodriguez;Thomas K. Karikari;Marc Suárez-Calvet;Claire Troakes

  • Plasma proteins predict conversion to dementia from prodromal disease

    Abdul Hye;Joanna Riddoch-Contreras;Alison L. Baird;Nicholas J. Ashton

  • Biomarkers for tau pathology

    Michael Schöll;Michael Schöll;Michael Schöll;Anne Maass;Niklas Mattsson;Nicholas J. Ashton

  • Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.

    Alexis Moscoso;Michel J Grothe;Michel J Grothe;Nicholas J Ashton;Thomas K Karikari

  • Pathogenesis of hypertensive retinopathy. An experimental study in the monkey.

    A Garner;N Ashton;R Tripathi;E M Kohner

  • Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

    Thomas K. Karikari;Andréa L. Benedet;Nicholas J. Ashton;Juan Lantero Rodriguez

  • Plasma p‐tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post‐mortem and improves the clinical characterisation of cognitive decline: Developing topics

    Juan Lantero Rodriguez;Thomas K Karikari;Marc Suarez-Calvet;Claire Troakes

Frequent Co-Authors

Kaj Blennow
Kaj Blennow University of Gothenburg
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Michael Schöll
Michael Schöll University of Gothenburg
Simon Lovestone
Simon Lovestone University of Oxford
Pedro Rosa-Neto
Pedro Rosa-Neto McGill University
Dag Aarsland
Dag Aarsland King's College London
Serge Gauthier
Serge Gauthier McGill University
Oskar Hansson
Oskar Hansson Lund University
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
Alberto Lleó
Alberto Lleó Hospital de la Santa Creu i Sant Pau

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond a traditional medical degree, there are several related online degrees and career pathways that offer flexibility and diverse opportunities within healthcare. Many students consider nursing due to high demand and clear pathways for advancement. For those interested in nursing but concerned about entrance exams, it's important to note that not all institutions have the same admission requirements—learn more in this guide: do all nursing schools require the teas.

If you’re looking to move into healthcare management, earning a healthcare administration accelerated degree online can position you for leadership roles faster than traditional programs. Nurses aiming for advanced practice roles may pursue specialized bridge programs like the rn to np bridge program, which prepares registered nurses for nurse practitioner status and increased responsibility.

Additionally, those passionate about wellness and nutrition can explore the best online food science degree programs, opening doors to roles in dietetics, food safety, and public health. Each of these pathways expands your potential in the healthcare field and can often be started or completed online for greater accessibility.

Best Scientists Citing Nicholas J. Ashton

Trending Scientists

Recently Published Articles